Annual Drug Patent Expirations for DAURISMO
Daurismo is a drug marketed by Pfizer and is included in one NDA. It is available from one supplier. There are four patents protecting this drug.
This drug has eigthy-two patent family members in fifty countries.
The generic ingredient in DAURISMO is glasdegib maleate. One supplier is listed for this compound. Additional details are available on the glasdegib maleate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
